Ureaplasma urealyticum, erythromycin and respiratory morbidity in high- risk preterm neonates

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 10, 1998, Pages 1079-1084

  Jonsson B ^a   Rylander, M ^a   Faxelius, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Erythromycin; Preterm infants; Respiratory morbidity; Risk factors; Ureaplasma

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; UREAPLASMA UREALYTICUM; VAGINAL DELIVERY;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; MALE; MORBIDITY; PREGNANCY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 0031697706     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352598750031428     Document Type: Article

References (29)

1. Northway W. Bronchopulmonary dysplasia: Twenty-five years later. Pediatrics 1992; 89: 969-73
2. Zimmerman J. Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin Perinatol 1995; 22: 429-56
3. Wang EEL, Ohlsson A, Kellner J. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a metaanalysis. J Pediatr 1995; 127: 640-4
4. Jonsson B, Karell A, Ringertz S, Rylander M, Faxelius G. Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Paediatr 1994; 83: 927-30
5. Bancalari E. Bronchopulmonary dysplasia: Clinical presentation. J Pediatr 1979; 95: 819-23
6. Crouse D, Odrezin G, Cutter G, Reese J, Hamrick W, Waites K, Cassell G. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis 1993; 17 Suppl 1: S122-30
7. Panero A, Pacifico L, Rossi N, Roggini M, Chiesa C. Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cell response. Arch Dis Child 1995; 73: F37-40
8. Shepard M, Lunceford C. Differential agar medium (A7) for identification of Ureaplasma urealyticum (Human T Mycoplasmas) in primary cultures of clinical material. J Clin Microbiol 1976; 3: 613-25
9. Shepard MC. Culture media for ureaplasmas. In: Razin S, Tully J, ed. Methods in Mycoplasmology, Vol 1. New York: Academic Press, 1983: 137-46
10. Gonzalez A, Sosenko I, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128: 470-8
11. Pacifico L, Panero A, Roggini M, Rossi N, Bucci G, Chiesa C. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997; 16: 579-86
12. Goldenberg R, Andrews W. Editorial: Intrauterine infection and why preterm prevention programs have failed. Am J Publ Health 1996; 86: 781-3
13. Eschenbach D. Ureplasma urealyticum and premature birth. Clin Infect Dis 1993; 17: S100-6
14. Cassell G, Waites K, Watson H, Crouse D, Harasawa R. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993; 6: 69-87
15. Hillier S, Witkin S, Krohn M, Watts D, Kiviat N, Eschenbach D. The relationship of amniotic fluid cytokines and preterm delivery, amniolic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstetr Gynecol 1993; 81: 941-8
16. Watterberg K, Deniers L, Scott S, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-5
17. Balady P, Farkouh L, RS G. Intra-amniotic infection and premature rupture of the membranes. Clin Perinatol 1997; 24: 43-57
18. Walsh W, Butler J, Coalson J, Hensley D, Cassell G, deLemos R. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin Infect Dis 1993; 17: S158-62
19. Walsh WF, Stanley S, Lally KP, Stribley RE, Treece DB, McCleskey F, Null DM. Ureaplasma urealyticum demonstrated by open lung biopsy in newborns with chronic lung disease. Pediatr Infect Dis J 1991; 10: 823-7
20. Silverman M. Chronic lung disease of prematurity: are we to cautious with steroids? Eur J Pediatr 1994; 153 Suppl 2: S30-5
21. Jones C, Cayabyab R, Kwong K, Stotts C, Wong B, Hamdan H, et al. Undetectable Interleukin (IL)-10 and persistent IL-8 expression in early hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-75
22. Damman O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1-8
23. Waites K, Sims P, Crouse D, Geerts M, Shoup R, Hamrick W, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J 1994; 13: 287-93
24. Waites K, Crouse D, Cassell G. Therapeutic considerations for Ureaplasma urealyticum Infection in neonates. Clin Infect Dis 1993; 17: S208-14
25. Farrar H, Walsh-Sukys M, Kyllonen K, al e. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the litterature. Pediatr Infect Dis J 1993; 12: 688-91
26. Heggie A, Jacobs M, Butler V, Baley J, Boxerbaum B. Frequency and significance of isolation of Ureaplasama urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birthweight infants. J Pediatr 1994; 124: 956-61
27. Lyon A, McColm J, Middlemist L, McIntosh N. Effect of erythromycin on lung disease in infants 30 weeks or less gestation. Early Hum Devel 1997; 49: 214-54
28. Hauth J, Goldenberg R, Andrews W, DuBard M, Copper R. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732-6
29. Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A, Schemper M. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: A metaanalysis. Am J Obstet Gynecol 1996; 174: 589-97